Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevention of heart failure with chlorthalidone in ALLHAT: placing the results into perspective.

× No keyword cloud information.

15 in total

1. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.

Authors: Paula T Einhorn; Barry R Davis; Barry M Massie; William C Cushman; Linda B Piller; Lara M Simpson; Daniel Levy; Chuke E Nwachuku; Henry R Black
Journal: Am Heart J Date: 2007-01 Impact factor: 4.749

Review 2. Thiazide-type diuretics and beta-adrenergic blockers as first-line drug treatments for hypertension.

Authors: Jeffrey A Cutler; Barry R Davis
Journal: Circulation Date: 2008-05-20 Impact factor: 29.690

3. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:
Journal: JAMA Date: 2002-12-18 Impact factor: 56.272

4. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Authors: Barry R Davis; Linda B Piller; Jeffrey A Cutler; Curt Furberg; Kay Dunn; Stanley Franklin; David Goff; Frans Leenen; Syed Mohiuddin; Vasilios Papademetriou; Michael Proschan; Allan Ellsworth; John Golden; Pedro Colon; Richard Crow
Journal: Circulation Date: 2006-05-01 Impact factor: 29.690

5. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190

6. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

Authors: Kenneth Jamerson; Michael A Weber; George L Bakris; Björn Dahlöf; Bertram Pitt; Victor Shi; Allen Hester; Jitendra Gupte; Marjorie Gatlin; Eric J Velazquez
Journal: N Engl J Med Date: 2008-12-04 Impact factor: 91.245

7. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

Authors: Bruce M Psaty; Thomas Lumley; Curt D Furberg; Gina Schellenbaum; Marco Pahor; Michael H Alderman; Noel S Weiss
Journal: JAMA Date: 2003-05-21 Impact factor: 56.272

8. Antihypertensive prescriptions for newly treated patients before and after the main antihypertensive and lipid-lowering treatment to prevent heart attack trial results and seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure guidelines.

Authors: Paul Muntner; Marie Krousel-Wood; Amanda D Hyre; Erin Stanley; William C Cushman; Jeffrey A Cutler; Linda B Piller; Gary A Goforth; Paul K Whelton
Journal: Hypertension Date: 2009-02-16 Impact factor: 10.190

9. Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group.

Authors:
Journal: JAMA Date: 1982-09-24 Impact factor: 56.272

10. Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Authors: Barry R Davis; John B Kostis; Lara M Simpson; Henry R Black; William C Cushman; Paula T Einhorn; Michael A Farber; Charles E Ford; Daniel Levy; Barry M Massie; Shah Nawaz
Journal: Circulation Date: 2008-11-10 Impact factor: 29.690